cycloheximide has been researched along with Hematologic Malignancies in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, YS; Kim, KM; Lee, K; Park, HY | 1 |
1 other study(ies) available for cycloheximide and Hematologic Malignancies
Article | Year |
---|---|
Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Topics: Apoptosis; bcl-2-Associated X Protein; Carrier Proteins; Cycloheximide; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Membrane Glycoproteins; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 6b; Signal Transduction; Tumor Cells, Cultured | 2000 |